A clinical trial found that metformin, a drug typically used for type 2 diabetes, reduced insulin requirements by around 12% in adults with type 1 diabetes.

Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, announced the publication of a paper in the journal The Lancet Diabetes & Endocrinology that provides the ...

NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, announced the publication of a paper in the journal Diabetes that ...

The discovery, featured on the cover of Analytical Chemistry, could potentially slow the progression to full-blown diabetes.

Discovery featured on cover of Analytical Chemistry could potentially slow progression to full-blown diabetes.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced it has received an ...

NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Breakthrough T1D International, the leading global type 1 diabetes (T1D) research and advocacy organization, in partnership with Friends of Mewar and UNICEF ...

NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, has kicked off a series of Breakthrough T1D Walks ...

Youth Delegates Living with Type 1 Diabetes and Katie Bone, American Ninja Warrior Champion Who Lives with Type 1 Diabetes Provided Testimony at a Senate Appropriations Committee Hearing More than 1.5 ...

The MarketWatch News Department was not involved in the creation of this content. Youth Delegates Living with Type 1 Diabetes and Katie Bone, American Ninja Warrior Champion who Lives with Type 1 ...

The annual Greater Boise Walk for Breakthrough T1D (Type 1 Diabetes) will be on October 11 at Julius M. Kleiner Memorial Park in Meridian. Check-in begins at 9 a.m. and the 3K walk opening ceremonies ...